相关实验视频

Updated: Jun 2, 2025

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice

A Magnetic Microbead Occlusion Model to Induce Ocular Hypertension-Dependent Glaucoma in Mice

Published on: March 23, 2016

拉帕素通过抑制mTORC1/2信号传递来保护葡萄皮质激素诱导的青光眼模型小鼠免受尾状网状纤维化

Yuning Song¹, Feifei Wang², Hongdou Luo¹

¹Affiliated Eye Hospital of Nanchang University, Jiangxi Medical College, Nanchang University, Jiangxi Research Institute of Ophthalmology & Visual Science, Jiangxi Provincial Key Laboratory for Ophthalmology, Jiangxi Clinical Research Center for Ophthalmic Disease, Nanchang, China.

European journal of pharmacology

|January 13, 2025

概括

拉巴胺素 (Rapa) 通过降低眼内压力 (IOP) 和状眼网 (TM) 损伤,保护免受葡萄糖皮质激素诱导的青光眼 (GIG). 它抑制纤维化和细胞骨变化,为GIG提供了一个新的治疗途径.

科学领域:

眼科医生眼科眼科
药理学药理学是指药理学的学科.
细胞生物学细胞生物学

背景情况:

葡萄糖皮质类药物 (GCs) 可能导致病态眼内压力 (IOP) 升高,导致视力丧失.
拉帕 (Rapa) 已知通过抑制视网膜质细胞激活和神经炎症,具有神经保护作用.
雷帕对青光眼中带状网 (TM) 的作用仍然没有得到充分的研究.

研究的目的:

在葡萄糖皮质类药物诱导的玻璃眼 (GIG) 模型中研究拉帕 (Rapa) 的保护作用和潜在机制.
为了确定Rapa是否可以减轻IOP升高,TM纤维化和视网膜质细胞 (RGC) 损伤由葡萄糖皮质类药物引起.

主要方法:

建立了一个葡萄糖皮质醇诱导的玻璃眼 (GIG) 模型.
管理Rapa评估其对IOP,TM纤维化和RGC损伤的影响.
利用培养的人类脊髓网状细胞 (HTMCs),用德甲 (Dex) 和Rapa处理,以分析细胞变化和通路激活.

主要成果:

在GIG模型中,Rapa显著抑制了德甲酸盐 (Dex-Ac) 诱导的IOP增加.
拉帕治疗改善了TM纤维化,并减少了RGC损伤.
在体外,Rapa抑制了德甲 (Dex) 诱导的HTMC纤维化和细胞骨变化,可能通过mTORC1和/或mTORC2通路的抑制.

结论:

拉帕显示出对葡萄糖皮质类药物诱导的玻璃眼 (GIG) 有显著的保护作用.
该机制涉及抑制TM纤维化和细胞骨变化,可能通过调节mTORC1/mTORC2通路.
这项研究为Rapa作为GIG的潜在治疗提供了新的理论基础.

关键词:

德克萨米他是一种纤维化纤维化纤维化眼光障碍眼光障碍眼光障碍眼光障碍拉帕米辛是一种脊柱状的网状网状网状网状网状网.在mTOROR中使用mTOR.

更多相关视频

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

A Model of Glaucoma Induced by Circumlimbal Suture in Rats and Mice

A Model of Glaucoma Induced by Circumlimbal Suture in Rats and Mice

Published on: October 5, 2018

相关概念视频

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...